腹腔镜辅助与超声引导腹横肌平面阻滞在微创结肠手术中的多中心随机对照试验
该多中心三臂随机对照优效性与非劣效性试验纳入340例择期微创结肠手术患者,比较超声引导TAP阻滞、腹腔镜辅助TAP阻滞与安慰剂。主要结局为术后24小时吗啡当量消耗量。结果显示腹腔镜辅助TAP优于安慰剂且非劣于超声引导TAP,但两者均未达到预设的10 mg吗啡最小临床重要差值。
要点
- 腹腔镜辅助TAP阻滞在减少24小时吗啡消耗上优于安慰剂,但差值未达临床重要阈值。
- 超声引导TAP阻滞与安慰剂相比无显著差异。
- 腹腔镜辅助TAP阻滞非劣于超声引导TAP阻滞(非劣效界值10 mg吗啡)。
核心结论
- 腹腔镜辅助TAP阻滞优于安慰剂且非劣于超声引导TAP阻滞,但两者均未达到预设的10 mg吗啡最小临床重要差值。
研究设计与样本
- 多中心三臂随机对照优效性与非劣效性临床试验,纳入340例择期微创结肠手术患者,随机分为超声引导TAP组、腹腔镜辅助TAP组和安慰剂组。
主要发现
- 超声引导TAP组与安慰剂组24小时吗啡消耗量无差异,差值为-1.4 mg(97.5%CI -6.8至4.0 mg;p=0.55)。
- 腹腔镜辅助TAP组优于安慰剂组,差值为-5.9 mg吗啡(97.5%CI -11.3至-0.5 mg;p=0.01)。
- 腹腔镜辅助TAP组非劣于超声引导TAP组,差值为-4.5 mg吗啡(98.75%CI -10.0至1.1 mg)。
关键数值与推荐
- 非劣效界值为10 mg吗啡当量。
- 最小临床重要差值为10 mg吗啡。
临床怎么用
- 在微创结肠手术的加速康复路径中,腹腔镜辅助TAP阻滞可作为超声引导TAP的替代选择,但镇痛获益幅度有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The transversus abdominis plane (TAP) block is the most widely used abdominal field block in colorectal surgery with a postoperative enhanced recovery pathway. We aimed to determine whether the laparoscopic-assisted and ultrasound-guided TAP (US-TAP) blocks provide superior pain relief compared with placebo. We separately investigated whether the laparoscopic-assisted technique was non-inferior to the ultrasound-guided technique in providing pain relief, with a non-inferiority margin of 10 mg morphine dose equivalents. METHODS: 340 patients undergoing elective minimally invasive colon surgery were randomly allocated to one of three groups: (1) US-TAP block, (2) laparoscopic-assisted TAP (L-TAP) block, or (3) placebo. Superiority and non-inferiority were tested for the primary outcome: 24-hour postoperative morphine equivalent consumption. Secondary outcomes, including patient-reported quality of recovery, were included in the superiority analysis. RESULTS: 127 patients were included in each block group and 86 in the placebo group. The US-TAP block was no different from placebo at -1.4 mg morphine (97.5% CI -6.8 to 4.0 mg; p=0.55). The L-TAP block was superior to placebo at -5.9 mg morphine (97.5% CI -11.3 to -0.5 mg; p=0.01) and non-inferior to the US-TAP block at -4.5 mg morphine (98.75% CI -10.0 to 1.1 mg). CONCLUSION: The L-TAP block was superior to placebo and non-inferior to the US-TAP block. However, neither met our predetermined estimate of the minimal clinically important difference of 10 mg morphine. TRIAL REGISTRATION NUMBER: NCT04311099.
引用
- Salmonsen CB, Lange KHW, Kleif J, et al. Transversus abdominis plane block in minimally invasive colon surgery: a multicenter three-arm randomized controlled superiority and non-inferiority clinical trial. Reg Anesth Pain Med. 2026. PMID: 39542642. doi:10.1136/rapm-2024-105712
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。